Observation on the clinical effect of acupoint catgut embedding combined with atorvastatin in the treatment of dyslipidemia

Community Health Service Center, Malu Town, Jiading District, Shanghai0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Volunteer to participate in the study and sign informed consent.
•2. The age is between 60 and 75 years old (including 60 and 75 years old), and the gender is unlimited.
•3. Serum total cholesterol >= 5.2mmol/l; serum triglyceride >= 1.7mmol/l; high-density lipoprotein < 1.0mmo1/l; low-density lipoprotein >= 3.4mmol/l; one or more of the above four indexes were met.
•4. At the same time, the above three items can be included in this study.

•1. Serious heart related diseases: LDL-C <= 2.07mmol/l when coronary heart disease and other critical patients do not take statins; myocardial infarction, unstable angina, stent surgery, coronary artery revascularization, coronary artery bypass surgery, cardiac surgery; grade II-IV heart failure; three months before admission: severe ventricular tachycardia, atrial fibrillation with rapid ventricular rate, supraventricular tachycardia.
•2. Patients who have received lipid-lowering treatment in the past three months or are taking drugs (such as heparin, thyroxine, etc.) that may affect lipid metabolism.
•3. Stroke, pulmonary embolism and deep vein thrombosis occurred 3 months before admission.
•4. ALT or ast were more than twice of the upper limit of normal.
•5. Renal insufficiency.
•6. CK (creatine kinase) is more than three times of the upper limit of normal; active infection.
•7. Type 1 diabetes; or poorly controlled type 2 diabetes (HbA1c > 8.5%).
•8. History of cancer.
•9. Subjects who are unreliable (such as drug abuse, unwillingness to comply with the agreement or mental illness), do not cooperate with the agreement or procedural requirements.
•Patients who meet any of the above conditions shall be excluded.

发起方

Community Health Service Center, Malu Town, Jiading District, Shanghai